Arno Therapeutics Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.44 |
Market Cap |
$59.22 K |
Shares Outstanding |
49.35 M |
Public Float |
- |
Address |
200 Route 31 North Flemington New Jersey 08822 United States |
Employees | - |
Website | http://www.arnothera.com |
Updated | 07/08/2019 |
Arno Therapeutics, Inc. operates as a biopharmaceutical company, which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs. It develops pre-clinical and clinical-stage product under the following brands: Onapristone, AR-42, and AR-12. The company was founded by Peter Morgan Kash, David M. |